117 related articles for article (PubMed ID: 7930768)
61. Classic and molecular cytogenetic analyses reveal chromosomal gains and losses correlated with survival in head and neck cancer patients.
Bérgamo NA; da Silva Veiga LC; dos Reis PP; Nishimoto IN; Magrin J; Kowalski LP; Squire JA; Rogatto SR
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):621-31. PubMed ID: 15701849
[TBL] [Abstract][Full Text] [Related]
62. Smith-Magenis syndrome deletion: a case with equivocal cytogenetic findings resolved by fluorescence in situ hybridization.
Juyal RC; Greenberg F; Mengden GA; Lupski JR; Trask BJ; van den Engh G; Lindsay EA; Christy H; Chen KS; Baldini A
Am J Med Genet; 1995 Sep; 58(3):286-91. PubMed ID: 8533833
[TBL] [Abstract][Full Text] [Related]
63. Loss of heterozygosity in mammary serine protease inhibitor (maspin) and p53 at chromosome 17 and 18 in oral cavity squamous cell carcinoma.
Choi KY; Choi HJ; Chung EJ; Lee DJ; Kim JH; Rho YS
Head Neck; 2015 Sep; 37(9):1239-45. PubMed ID: 24801268
[TBL] [Abstract][Full Text] [Related]
64. Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in-situ hybridization.
Cheville JC; Bromley C; Argenyi ZB
J Cutan Pathol; 1995 Dec; 22(6):546-50. PubMed ID: 8835173
[TBL] [Abstract][Full Text] [Related]
65. Numerical aberrations of chromosome 17 detected by FISH with DNA-specific probe in oral tumors.
Tsuji T; Mimura Y; Maeda K; Ida M; Sasaki K; Shinozaki F
Anticancer Res; 1994; 14(5A):1689-93. PubMed ID: 7847802
[TBL] [Abstract][Full Text] [Related]
66. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
[TBL] [Abstract][Full Text] [Related]
67. 18q- and 18q+ mosaicism in a mentally retarded boy.
Ausems MG; Bhola SL; Post-Blok CA; Hennekam RC; de France HF
Am J Med Genet; 1994 Nov; 53(3):296-9. PubMed ID: 7856666
[TBL] [Abstract][Full Text] [Related]
68. Chromosome duplications and deletions and their mechanisms of origin.
Tharapel AT; Michaelis RC; Velagaleti GV; Laundon CH; Martens PR; Buchanan PD; Teague KE; Tharapel SA; Wilroy RS
Cytogenet Cell Genet; 1999; 85(3-4):285-90. PubMed ID: 10449919
[TBL] [Abstract][Full Text] [Related]
69. Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescent in situ hybridization.
Hamon-Benais C; Ingster O; Terris B; Couturier-Turpin MH; Bernheim A; Feldmann G
Hepatology; 1996 Mar; 23(3):429-35. PubMed ID: 8617421
[TBL] [Abstract][Full Text] [Related]
70. Current treatment options: impact of cytogenetics on the course of myelodysplasia.
Galili N; Cerny J; Raza A
Curr Treat Options Oncol; 2007 Apr; 8(2):117-28. PubMed ID: 17634837
[TBL] [Abstract][Full Text] [Related]
71. Post-mortem studies on two patients with 1-2 band cytogenetic deletions: 10q26----qter and r(9)(p24q34).
Smith A; Evans WA; Woolnough H
Ann Genet; 1989; 32(4):220-4. PubMed ID: 2610488
[TBL] [Abstract][Full Text] [Related]
72. Cytogenetic abnormalities in a case of botryoid rhabdomyosarcoma.
Kadan-Lottick NS; Stork L; Ruyle SZ; Koyle M; Hunger SP; McGavran L
Med Pediatr Oncol; 2000 Apr; 34(4):293-5. PubMed ID: 10742076
[No Abstract] [Full Text] [Related]
73. Two simple translocations in a primary squamous cell carcinoma of the head and neck.
Tharapel SA; Lester EP
Cancer Genet Cytogenet; 1990 Jul; 47(1):131-4. PubMed ID: 2357683
[TBL] [Abstract][Full Text] [Related]
74. Cytogenetic findings in cervical carcinoma. A statistical approach.
Sreekantaiah C; De Braekeleer M; Haas O
Cancer Genet Cytogenet; 1991 May; 53(1):75-81. PubMed ID: 2036641
[TBL] [Abstract][Full Text] [Related]
75. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung.
Weston A; Willey JC; Modali R; Sugimura H; McDowell EM; Resau J; Light B; Haugen A; Mann DL; Trump BF
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5099-103. PubMed ID: 2567993
[TBL] [Abstract][Full Text] [Related]
76. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
Pitchford CW; Hettinga AC; Reichard KK
Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
[TBL] [Abstract][Full Text] [Related]
77. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
78. Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases.
Fayad L; Kantarjian H; O'Brien S; Seong D; Albitar M; Keating M; Talpaz M
Leukemia; 1997 May; 11(5):767-71. PubMed ID: 9180306
[TBL] [Abstract][Full Text] [Related]
79. Chromosomal changes in renal oncocytomas. Evidence that t(5;11)(q35;q13) may characterize a second subgroup of oncocytomas.
van den Berg E; Dijkhuizen T; Störkel S; de la Rivière GB; Dam A; Mensink HJ; Oosterhuis JW; de Jong B
Cancer Genet Cytogenet; 1995 Feb; 79(2):164-8. PubMed ID: 7889513
[TBL] [Abstract][Full Text] [Related]
80. Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features.
Mazzucchelli R; Barbisan F; Stramazzotti D; Montironi R; Lopez-Beltran A; Scarpelli M
Anal Quant Cytol Histol; 2005 Jun; 27(3):143-51. PubMed ID: 16121635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
